SCHEMBL7533286

SCHEMBL7533286

CCC(=O)Oc1cc(C)ccc1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.66
TDP1 Q9NUW8 3/20 0.53
GAA P10253 2/20 0.53
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
LMNA P02545 2/20 0.49
CYP2C9 P11712 2/20 0.49
HTT P42858 1/20 0.49
ALOX15 P16050 1/20 0.46
ESR1 P03372 2/20 0.46
HIF1A Q16665 2/20 0.46
KMT2A Q03164 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
TTR P02766 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C8 P10632 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15558301 0.87 ALOX15 (0.60) ACHETDP1GAASMN1; SMN2LMNA
SCHEMBL7537504 0.85 L3MBTL1 (0.59) ACHEGAASMN1; SMN2LMNAHTT
SCHEMBL11598343 0.84 TDP1 (0.51) ACHETDP1GAATSHRSMN1; SMN2
SCHEMBL29059062 0.84 TDP1 (0.51) ACHETDP1GAATSHRSMN1; SMN2
SCHEMBL29059269 0.84 TDP1 (0.51) ACHETDP1GAATSHRSMN1; SMN2
SCHEMBL11646714 0.84 TDP1 (0.51) ACHETDP1GAATSHRSMN1; SMN2
SCHEMBL29059334 0.84 HTT (0.51) ACHETDP1GAATSHRSMN1; SMN2
SCHEMBL28570128 0.84 ACHE (0.47) ACHETDP1GAASMN1; SMN2LMNA
SCHEMBL4084211 0.82 ACHE (0.57) ACHETDP1GAASMN1; SMN2LMNA
SCHEMBL28243849 0.82 TSHR (0.49) ACHETDP1GAATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
US-6265445-B1 CARDIOVASCULAR DISORDERS GYOGYSZERKUTATO INTEZET KFT (HU) 2001-07-24 US disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed